Skandinaviska Enskilda Banken (SEB)’s ChemoCentryx, Inc. CCXI Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-20,000	Closed	-$1.03M	–	932
2022 Q3	$1.03M	Buy	+20,000	New	+$827K	0.01%	673
2021 Q2	–	Sell	-18,073	Closed	-$926K	–	1161
2021 Q1	$926K	Buy	18,073 +14,673	+432%	+$883K	0.01%	849
2020 Q4	$211K	Buy	3,400 +1,200	+55%	+$68.7K	﹤0.01%	1002
2020 Q3	$121K	Sell	2,200 -6,300	-74%	-$339K	﹤0.01%	930
2020 Q2	$489K	Buy	+8,500	New	+$463K	﹤0.01%	814

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s CCXI Position: Q4 2022 in Review

Skandinaviska Enskilda Banken (SEB) sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 20,000 shares — an estimated $1.03M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in CCXI in Q2 2020 and held it in 5 quarters. The position peaked at $1.03M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Skandinaviska Enskilda Banken (SEB) reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 20,000 ChemoCentryx, Inc. shares in Q4 2022, an estimated $1.03M.
Skandinaviska Enskilda Banken (SEB) first reported a position in ChemoCentryx, Inc. in Q2 2020 and held it in 5 quarters.
Skandinaviska Enskilda Banken (SEB)'s ChemoCentryx, Inc. position peaked at $1.03M in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2022, filed 8 Feb 2023.